|
PDXP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.840000E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.28619999999014E-05 |
| Normal-vs-Stage2 |
1.870260E-02 |
| Normal-vs-Stage3 |
3.362100E-03 |
| Normal-vs-Stage4 |
1.295660E-03 |
| Stage1-vs-Stage2 |
7.361200E-01 |
| Stage1-vs-Stage3 |
9.611800E-01 |
| Stage1-vs-Stage4 |
1.149820E-01 |
| Stage2-vs-Stage3 |
8.137200E-01 |
| Stage2-vs-Stage4 |
1.360960E-01 |
| Stage3-vs-Stage4 |
1.345850E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.85410000003361E-06 |
| Normal-vs-AfricanAmerican |
4.611000E-04 |
| Normal-vs-Asian |
5.595900E-03 |
| Caucasian-vs-AfricanAmerican |
8.311600E-01 |
| Caucasian-vs-Asian |
1.060970E-01 |
| AfricanAmerican-vs-Asian |
9.775900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.73750000000462E-05 |
| Normal-vs-Female |
3.06360000001948E-06 |
| Male-vs-Female |
1.015470E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.62764999999121E-05 |
| Normal-vs-Extreme_Weight |
2.200300E-04 |
| Normal-vs-Obese |
7.170400E-04 |
| Normal-vs-Extreme_Obese |
1.474990E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.238230E-02 |
| Normal_Weight-vs-Obese |
3.131600E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.514800E-01 |
| Extreme_Weight-vs-Obese |
9.429400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.160400E-01 |
| Obese-vs-Extreme_Obese |
6.221200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.247500E-02 |
| Normal-vs-Age(41-60Yrs) |
7.78890000000532E-05 |
| Normal-vs-Age(61-80Yrs) |
2.244400E-04 |
| Normal-vs-Age(81-100Yrs) |
4.915700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.645800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.195800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.952000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.057000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.131000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.075400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.960400E-03 |
| Normal-VS-Type2 PRCC |
5.554600E-04 |
| Normal-VS-KIRP CIMP |
1.12539999985728E-07 |
| Normal-VS-Unclassified PRCC |
1.5024499999905E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.866200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.82399999999872E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
5.821400E-04 |
| Type2 PRCC-VS-KIRP CIMP |
3.361200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.320200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.517900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.160500E-03 |
| Normal-vs-N1 |
1.96409999999592E-05 |
| Normal-vs-N2 |
2.881400E-01 |
| N0-vs-N1 |
3.642100E-02 |
| N0-vs-N2 |
9.435200E-01 |
| N1-vs-N2 |
1.914220E-01 |
|
|
